 | Edgewise Therapeutics, Inc. | |||
| NasdaqGS : EWTX || Location: United States | ||||
$10.6+0.65 (+6.49%) |
0.11 M | 9.89 - 10.55 | ||
| Last Updated:08/12/2022 16:41 | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| July 29, 2022 | 3.507 M |
| July 15, 2022 | 3.401 M |
| June 30, 2022 | 3.125 M |
| June 15, 2022 | 3.216 M |
| May 31, 2022 | 3.170 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 03/31/2022 | -0.28 | -0.30 | -7.10% |
| 12/31/2021 | -0.25 | -0.26 | -4.00% |
| 09/30/2021 | -0.22 | -0.26 | -18.20% |
| 06/30/2021 | -0.18 | -0.21 | -16.70% |
| 03/31/2021 | -0.16 | -4.37 | -2631.20% |
EWTX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 49.800M | Shares Float | 14.337M |
| Short Float | 3.507M | Market Cap | 495.51M |
| Institution ownership | 0.00% | Insider ownership | 1.150% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | 2.84 | Forward EPS | -1.87 |